Rosacea
Conditions
Interventions
Experimental group:Bifidobacterium III
Live combined bacteria (2 capsules bid)
Control group:Placebo (2 capsules bid)
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis consistent with rosacea (according to the 2017 Global ROSacea Consensus, diagnosis can be made if any of the following are present: fixed erythema in the middle of the face, with a characteristic pattern of periodic exacerbations; rhinophyma changes; The following 2 to 3 are diagnostic Broken: flushed; papules and pustules; telangiectasia; ocular symptoms). 2. Age 18 to 60 years. 3. No serious organic diseases. 4. Patient agrees to participate in this clinical trial and signs written informed consent.
Exclusion criteria
Exclusion criteria: 1. Age less than 18 years or older than 60 years. 2. Those with mental illness and cognitive impairment. 3. Have taken drugs or preparations that interfere with the intestinal flora (such as antibiotics, probiotics, etc.) in the past 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The CEA rosacea erythema rating scale was used; | — |
Secondary
| Measure | Time frame |
|---|---|
| The middle part of the NRS rosacea composite score was used Index comprehensive score; | — |
Countries
China
Contacts
Public ContactXian Jiang
West China Hospital of Sichuan University
Outcome results
None listed